CTI Clinical Trial and Consulting Services
CTI Clinical Trial and Consulting Services was founded in 1999 to provide therapeutic expertise to the pharmaceutical and biotechnology industries, and is currently a dynamic global drug and device development organization providing concept to commercialization services. The company has experienced consistent and significant growth, evolving from a US-based organization to a multi-national corporation, attributed to uncompromising quality standards in talent, project performance, and abilities to exceed sponsors’ goals. CTI’s focused therapeutic approach provides pharmaceutical, biotechnology and startup firms with clinical and disease area expertise from a unique mix of academic, medical and industry specialists and rich intellectual capital in transplantation, immunology, infectious diseases, hematology, cardiology, nephrology, hepatology, regenerative medicine and rare diseases. CTI has a passion for helping life-changing therapies succeed in chronically and critically ill patient populations.
Locations
- Africa
- APAC
- Australia
- Europe
- North America
- South America
Therapeutic Areas
- Cardiovascular
- CNS
- Dermatology
- Diabetes
- Endocrinology
- Gastroenterology
- Genetic Diseases
- Hematology
- Hepatology
- Immunology
- Infectious Diseases
- Inflammation
- Metabolic Diseases
- Musculoskeletal
- Nephrology
- Neurology
- Obstetrics / Gynecology
- Oncology
- Ophthalmology
- Pediatrics / Neonatology
- Pharmacology / Toxicology
- Pulmonary
- Respiratory
- Rheumatology
- Sleep
- Surgery
- Thrombosis
- Transplants
- Vaccines